tykhr
sign in
free sign up
Organon & Co
Drug Manufacturers - General
Healthcare
OGN
261 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
10.61
52 week high
20.52
high
10.83
52 week low
0.00
low
10.53
growth
-44.96 %
previous Close
10.57
P/E ratio
market cap
2.64 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
-100.00 %
net profit margin
0.00 %
-5.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top